Vault-13

Avidity Partners Management LP

DALLAS, TX · CIK 1791827 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2020 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Dallas, TX (main office)United States United Statesabout 5
New York, NYUnited States United States2

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$2.4bn reported value -16.4% vs Q1 2024
85positions
32.9%in top 10
18 new 28 added 25 reduced 20 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 245,000 $109.0m4.63% 4.63% AddedShares held: Q3 2023 0, Q4 2023 85.0k, Q1 2024 226.0k, Q2 2024 245.0k +19.0k +19,000 8.4%
2 BOSTON SCIENTIFIC CORP COM BSX BSX 1,170,100 $90.1m3.83% 3.83% ReducedShares held: Q3 2023 2.1m, Q4 2023 1.9m, Q1 2024 2.0m, Q2 2024 1.2m -785.9k -785,900 -40.2%
3 NATERA INC COM NTRA NTRA 766,500 $83.0m3.53% 3.53% ReducedShares held: Q3 2023 899.0k, Q4 2023 1.1m, Q1 2024 803.3k, Q2 2024 766.5k -36.8k -36,800 -4.6%
4 ARVINAS INC COM ARVN ARVN 2,987,845 $79.5m3.38% 3.38% AddedShares held: Q3 2023 2.6m, Q4 2023 3.0m, Q1 2024 3.0m, Q2 2024 3.0m +2.7k +2,655 0.1%
5 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 1,120,000 $75.6m3.21% 3.21% AddedShares held: Q3 2023 715.0k, Q4 2023 1.2m, Q1 2024 1.0m, Q2 2024 1.1m +115.0k +115,000 11.4%
6 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 2,917,231 $75.5m3.21% 3.21% AddedShares held: Q3 2023 1.2m, Q4 2023 1.2m, Q1 2024 2.7m, Q2 2024 2.9m +199.7k +199,677 7.3%
7 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,335,000 $68.5m2.91% 2.91% AddedShares held: Q3 2023 2.8m, Q4 2023 4.0m, Q1 2024 2.4m, Q2 2024 3.3m +922.5k +922,500 38.2%
8 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 491,000 $67.6m2.87% 2.87% ReducedShares held: Q3 2023 652.1k, Q4 2023 658.0k, Q1 2024 536.5k, Q2 2024 491.0k -45.5k -45,500 -8.5%
9 AVANTOR INC COM AVTR AVTR 3,086,000 $65.4m2.78% 2.78% AddedShares held: Q3 2023 0, Q4 2023 2.1m, Q1 2024 2.7m, Q2 2024 3.1m +391.0k +391,000 14.5%
10 THE CIGNA GROUP COM CI CI 184,500 $61.0m2.59% 2.59% UnchangedShares held: Q3 2023 207.7k, Q4 2023 0, Q1 2024 184.5k, Q2 2024 184.5k
11 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 544,500 $58.1m2.47% 2.47% ReducedShares held: Q3 2023 797.5k, Q4 2023 489.1k, Q1 2024 584.0k, Q2 2024 544.5k -39.5k -39,500 -6.8%
12 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 222,000 $53.9m2.29% 2.29% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 243.0k, Q2 2024 222.0k -21.0k -21,000 -8.6%
13 REGENERON PHARMACEUTICALS COM REGN REGN 48,000 $50.4m2.14% 2.14% ReducedShares held: Q3 2023 58.0k, Q4 2023 68.0k, Q1 2024 68.0k, Q2 2024 48.0k -20.0k -20,000 -29.4%
14 ILLUMINA INC COM ILMN ILMN 478,000 $49.9m2.12% 2.12% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 464.1k, Q2 2024 478.0k +13.9k +13,900 3.0%
15 TENET HEALTHCARE CORP COM NEW THC THC 372,000 $49.5m2.10% 2.10% ReducedShares held: Q3 2023 963.8k, Q4 2023 871.0k, Q1 2024 601.0k, Q2 2024 372.0k -229.0k -229,000 -38.1%
16 ABBVIE INC COM ABBV ABBV 277,800 $47.6m2.02% 2.02% AddedShares held: Q3 2023 0, Q4 2023 284.4k, Q1 2024 227.0k, Q2 2024 277.8k +50.8k +50,800 22.4%
17 THERMO FISHER SCIENTIFIC INC COM TMO TMO 80,000 $44.2m1.88% 1.88% AddedShares held: Q3 2023 0, Q4 2023 182.6k, Q1 2024 36.6k, Q2 2024 80.0k +43.4k +43,400 118.6%
18 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 1,075,000 $42.2m1.79% 1.79% AddedShares held: Q3 2023 500.0k, Q4 2023 1.1m, Q1 2024 864.0k, Q2 2024 1.1m +211.0k +211,000 24.4%
19 BLUEPRINT MEDICINES CORP COM BPMC BPMC 383,000 $41.3m1.75% 1.75% ReducedShares held: Q3 2023 751.6k, Q4 2023 615.0k, Q1 2024 426.0k, Q2 2024 383.0k -43.0k -43,000 -10.1%
20 CG ONCOLOGY INC COM CGON CGON 1,296,225 $40.9m1.74% 1.74% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.5m, Q2 2024 1.3m -158.5k -158,540 -10.9%
21 MERCK & CO INC COM MRK MRK 325,000 $40.2m1.71% 1.71% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 502.0k, Q2 2024 325.0k -177.0k -177,000 -35.3%
22 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 960,000 $39.5m1.68% 1.68% AddedShares held: Q3 2023 544.0k, Q4 2023 844.5k, Q1 2024 933.5k, Q2 2024 960.0k +26.5k +26,500 2.8%
23 IDEAYA BIOSCIENCES INC COM IDYA IDYA 1,117,000 $39.2m1.67% 1.67% AddedShares held: Q3 2023 2.1m, Q4 2023 1.5m, Q1 2024 799.7k, Q2 2024 1.1m +317.3k +317,300 39.7%
24 DANAHER CORPORATION COM DHR DHR 150,000 $37.5m1.59% 1.59% AddedShares held: Q3 2023 176.6k, Q4 2023 290.0k, Q1 2024 143.8k, Q2 2024 150.0k +6.2k +6,200 4.3%
25 JANUX THERAPEUTICS INC COM JANX JANX 840,219 $35.2m1.50% 1.50% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 384.2k, Q2 2024 840.2k +456.0k +455,974 118.7%
26 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 110,000 $35.0m1.49% 1.49% ReducedShares held: Q3 2023 0, Q4 2023 237.2k, Q1 2024 217.0k, Q2 2024 110.0k -107.0k -107,000 -49.3%
27 INCYTE CORP COM INCY INCY 529,000 $32.1m1.36% 1.36% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 529.0k
28 SURGERY PARTNERS INC COM SGRY SGRY 1,306,477 $31.1m1.32% 1.32% ReducedShares held: Q3 2023 1.3m, Q4 2023 1.2m, Q1 2024 1.4m, Q2 2024 1.3m -138.5k -138,523 -9.6%
29 PERSPECTIVE THERAPEUTICS INC COM NEW CATX CATX 3,037,668 $30.3m1.29% 1.29% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 3.0m
30 AXSOME THERAPEUTICS INC COM AXSM AXSM 376,000 $30.3m1.29% 1.29% ReducedShares held: Q3 2023 296.8k, Q4 2023 459.4k, Q1 2024 431.0k, Q2 2024 376.0k -55.0k -55,000 -12.8%
31 XENON PHARMACEUTICALS INC COM XENE XENE 754,000 $29.4m1.25% 1.25% AddedShares held: Q3 2023 321.4k, Q4 2023 816.0k, Q1 2024 710.0k, Q2 2024 754.0k +44.0k +44,000 6.2%
32 DEXCOM INC COM DXCM DXCM 259,000 $29.4m1.25% 1.25% AddedShares held: Q3 2023 377.7k, Q4 2023 0, Q1 2024 176.9k, Q2 2024 259.0k +82.1k +82,100 46.4%
33 REVOLUTION MEDICINES INC COM RVMD RVMD 755,000 $29.3m1.25% 1.25% AddedShares held: Q3 2023 657.2k, Q4 2023 60.0k, Q1 2024 635.0k, Q2 2024 755.0k +120.0k +120,000 18.9%
34 INSMED INC COM PAR $.01 INSM INSM 430,000 $28.8m1.22% 1.22% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 430.0k
35 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 400,000 $27.4m1.16% 1.16% ReducedShares held: Q3 2023 801.1k, Q4 2023 710.0k, Q1 2024 600.0k, Q2 2024 400.0k -200.0k -200,000 -33.3%
36 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,559,826 $27.2m1.16% 1.16% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.6m
37 GLAUKOS CORP COM GKOS GKOS 224,000 $26.5m1.13% 1.13% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 224.0k, Q2 2024 224.0k
38 NEUROGENE INC COM NGNE NGNE 727,537 $26.5m1.12% 1.12% AddedShares held: Q3 2023 0, Q4 2023 466.2k, Q1 2024 465.2k, Q2 2024 727.5k +262.3k +262,300 56.4%
39 ARGENX SE SPONSORED ADR ARGX ARGX 60,500 $26.0m1.11% 1.11% NewShares held: Q3 2023 80.6k, Q4 2023 31.0k, Q1 2024 0, Q2 2024 60.5k
40 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 731,104 $25.0m1.06% 1.06% ReducedShares held: Q3 2023 1.1m, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 731.1k -411.7k -411,746 -36.0%
41 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 531,000 $24.1m1.03% 1.03% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 225.0k, Q2 2024 531.0k +306.0k +306,000 136.0%
42 IMMUNOVANT INC COM IMVT IMVT 908,000 $24.0m1.02% 1.02% AddedShares held: Q3 2023 1.2m, Q4 2023 245.0k, Q1 2024 505.0k, Q2 2024 908.0k +403.0k +403,000 79.8%
43 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 1,100,000 $23.7m1.01% 1.01% AddedShares held: Q3 2023 1.6m, Q4 2023 1.7m, Q1 2024 1.0m, Q2 2024 1.1m +75.0k +75,000 7.3%
44 LANTHEUS HLDGS INC COM LNTH LNTH 290,000 $23.3m0.99% 0.99% ReducedShares held: Q3 2023 558.4k, Q4 2023 380.0k, Q1 2024 480.0k, Q2 2024 290.0k -190.0k -190,000 -39.6%
45 VAXCYTE INC COM PCVX PCVX 284,000 $21.4m0.91% 0.91% UnchangedShares held: Q3 2023 756.2k, Q4 2023 570.1k, Q1 2024 284.0k, Q2 2024 284.0k
46 APOGEE THERAPEUTICS INC COM COM 487,000 $19.2m0.81% 0.81% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 384.9k, Q2 2024 487.0k +102.1k +102,107 26.5%
47 JASPER THERAPEUTICS INC COM NEW JSPR JSPR 782,000 $17.8m0.75% 0.75% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 760.0k, Q2 2024 782.0k +22.0k +22,000 2.9%
48 NEUMORA THERAPEUTICS INC. COM NMRA NMRA 1,800,000 $17.7m0.75% 0.75% UnchangedShares held: Q3 2023 1.8m, Q4 2023 2.0m, Q1 2024 1.8m, Q2 2024 1.8m
49 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 398,000 $17.6m0.75% 0.75% ReducedShares held: Q3 2023 967.0k, Q4 2023 685.0k, Q1 2024 668.3k, Q2 2024 398.0k -270.3k -270,300 -40.5%
50 GILEAD SCIENCES INC COM GILD GILD 255,000 $17.5m0.74% 0.74% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 255.0k
51 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 1,620,000 $16.7m0.71% 0.71% ReducedShares held: Q3 2023 1.6m, Q4 2023 1.7m, Q1 2024 1.7m, Q2 2024 1.6m -115.0k -115,000 -6.6%
52 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 205,000 $16.0m0.68% 0.68% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 160.0k, Q2 2024 205.0k +45.0k +45,000 28.1%
53 KEROS THERAPEUTICS INC COM KROS KROS 343,200 $15.7m0.67% 0.67% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 209.7k, Q2 2024 343.2k +133.5k +133,500 63.7%
54 BIOHAVEN LTD COM BHVN BHVN 450,000 $15.6m0.66% 0.66% AddedShares held: Q3 2023 1.3m, Q4 2023 1.1m, Q1 2024 75.0k, Q2 2024 450.0k +375.0k +375,000 500.0%
55 SANOFI SPONSORED ADR SNY SNY 315,000 $15.3m0.65% 0.65% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 315.0k
56 REGENXBIO INC COM RGNX RGNX 1,300,064 $15.2m0.65% 0.65% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.3m, Q2 2024 1.3m
57 CONTEXT THERAPEUTICS INC COM CNTX CNTX 7,419,355 $14.9m0.63% 0.63% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 7.4m
58 EXACT SCIENCES CORP COM EXAS EXAS 338,500 $14.3m0.61% 0.61% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 338.5k
59 PRIVIA HEALTH GROUP INC COM PRVA PRVA 764,200 $13.3m0.56% 0.56% UnchangedShares held: Q3 2023 1.5m, Q4 2023 1.3m, Q1 2024 764.2k, Q2 2024 764.2k
60 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 559,300 $10.7m0.46% 0.46% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 475.0k, Q2 2024 559.3k +84.3k +84,300 17.8%
61 IMMUNOME INC COM IMNM IMNM 873,891 $10.6m0.45% 0.45% UnchangedShares held: Q3 2023 0, Q4 2023 1.3m, Q1 2024 873.9k, Q2 2024 873.9k
62 IMMUNIC INC COM COM 8,902,972 $9.9m0.42% 0.42% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 8.9m, Q2 2024 8.9m
63 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 215,600 $9.8m0.41% 0.41% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 215.6k
64 CYBIN INC COM COM 34,884,000 $9.5m0.40% 0.40% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 34.9m, Q2 2024 34.9m
65 SYROS PHARMACEUTICALS INC COM NEW SYRS SYRS 1,673,538 $8.6m0.37% 0.37% UnchangedShares held: Q3 2023 1.6m, Q4 2023 1.7m, Q1 2024 1.7m, Q2 2024 1.7m
66 COGENT BIOSCIENCES INC COM COGT COGT 1,000,706 $8.4m0.36% 0.36% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 445.7k, Q2 2024 1.0m +555.0k +555,000 124.5%
67 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 200,000 $6.8m0.29% 0.29% ReducedShares held: Q3 2023 348.2k, Q4 2023 300.2k, Q1 2024 286.4k, Q2 2024 200.0k -86.4k -86,400 -30.2%
68 TYRA BIOSCIENCES INC COM TYRA TYRA 373,000 $6.0m0.25% 0.25% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 373.0k
69 UIPATH INC CL A PATH PATH 362,000 $4.6m0.20% 0.20% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 362.0k
70 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 195,000 $4.6m0.19% 0.19% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 195.0k
71 IMMATICS N.V SHS IMTX IMTX 393,100 $4.6m0.19% 0.19% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 393.1k
72 IONIS PHARMACEUTICALS INC COM IONS IONS 93,000 $4.4m0.19% 0.19% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 130.0k, Q2 2024 93.0k -37.0k -37,000 -28.5%
73 ARCA BIOPHARMA INC COM COM 1,000,000 $3.8m0.16% 0.16% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.0m
74 EDITAS MEDICINE INC COM EDIT EDIT 816,000 $3.8m0.16% 0.16% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 816.0k
75 INTELLIA THERAPEUTICS INC COM NTLA NTLA 170,000 $3.8m0.16% 0.16% NewShares held: Q3 2023 379.1k, Q4 2023 447.4k, Q1 2024 0, Q2 2024 170.0k
76 COLLEGIUM PHARMACEUTICAL INC COM COLL COLL 117,000 $3.8m0.16% 0.16% ReducedShares held: Q3 2023 350.2k, Q4 2023 361.4k, Q1 2024 361.4k, Q2 2024 117.0k -244.4k -244,400 -67.6%
77 PRIME MEDICINE INC COM PRME PRME 694,000 $3.6m0.15% 0.15% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.0m, Q2 2024 694.0k -1.3m -1,296,000 -65.1%
78 AC IMMUNE SA SHS ACIU ACIU 825,000 $3.3m0.14% 0.14% ReducedShares held: Q3 2023 3.0m, Q4 2023 4.5m, Q1 2024 4.5m, Q2 2024 825.0k -3.6m -3,645,000 -81.5%
79 KEZAR LIFE SCIENCES INC COM COM 5,026,000 $3.0m0.13% 0.13% UnchangedShares held: Q3 2023 6.0m, Q4 2023 5.0m, Q1 2024 5.0m, Q2 2024 5.0m
80 SCYNEXIS INC COM NEW COM NEW 1,448,728 $2.9m0.12% 0.12% UnchangedShares held: Q3 2023 1.3m, Q4 2023 1.4m, Q1 2024 1.4m, Q2 2024 1.4m
81 KARYOPHARM THERAPEUTICS INC COM COM 2,018,500 $1.8m0.07% 0.07% ReducedShares held: Q3 2023 8.3m, Q4 2023 8.3m, Q1 2024 8.3m, Q2 2024 2.0m -6.3m -6,280,070 -75.7%
82 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 350,000 $1.7m0.07% 0.07% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 350.0k
83 HYPERFINE INC COM CL A HYPR HYPR 1,188,178 $1.0m0.04% 0.04% UnchangedShares held: Q3 2023 1.2m, Q4 2023 1.2m, Q1 2024 1.2m, Q2 2024 1.2m
84 CAREMAX INC CL A NEW CL A NEW 21,200 $59.1k0.00% 0.00% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 21.2k, Q2 2024 21.2k
85 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 12,136 $1.9k0.00% 0.00% ReducedShares held: Q3 2023 89.5k, Q4 2023 89.5k, Q1 2024 89.5k, Q2 2024 12.1k -77.4k -77,407 -86.5%

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
FUSION PHARMACEUTICALS INC 6,500,328 $138.6m6.5m shares
ALIGN TECHNOLOGY INC ALGN ALGN 189,000 $62.0m189.0k shares
ELI LILLY & CO LLY LLY 70,000 $54.5m70.0k shares
ALPINE IMMUNE SCIENCES INC NVLS NVLS 1,174,700 $46.6m1.2m shares
CVS HEALTH CORP CVS CVS 545,000 $43.5m545.0k shares
CARIBOU BIOSCIENCES INC CRBU CRBU 5,785,352 $29.7m5.8m shares
MCKESSON CORP MCK MCK 33,300 $17.9m33.3k shares
VERA THERAPEUTICS INC VERA VERA 383,500 $16.5m383.5k shares
ASTRIA THERAPEUTICS INC CATB CATB 982,000 $13.8m982.0k shares
CYTOKINETICS INC CYTK CYTK 166,000 $11.6m166.0k shares
RADNET INC RDNT RDNT 238,000 $11.6m238.0k shares
ACADIA PHARMACEUTICALS INC ACAD ACAD 588,500 $10.9m588.5k shares
CENTURY THERAPEUTICS INC IPSC IPSC 1,221,555 $5.1m1.2m shares
KYVERNA THERAPEUTICS INC KYTX KYTX 202,333 $5.0m202.3k shares
EMERGENT BIOSOLUTIONS INC EBS EBS 1,908,000 $4.8m1.9m shares
AN2 THERAPEUTICS INC ANTX ANTX 1,150,000 $3.7m1.1m shares
GINKGO BIOWORKS HOLDINGS INC 3,000,000 $3.5m3.0m shares
X4 PHARMACEUTICALS INC 2,413,000 $3.4m2.4m shares
PACIFIC BIOSCIENCES CALIF IN PACB PACB 675,000 $2.5m675.0k shares
KODIAK SCIENCES INC KOD KOD 300,000 $1.6m300.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
IMMUNIC INC 13G · filed 2026-04-17 9.9% +5.1 pts 13G 2026-04-17
CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2026-05-12 CNTX 8.7%≈ $4.6m -1.2 pts 13G 2026-05-12
PERSPECTIVE THERAPEUTICS INC CATX · 13G · filed 2026-03-10 CATX 5.3%≈ $20.6m +1.1 pts 13G 2026-03-10